Skip to content

PHARMACIE MULLER

Active
Private limited companyfounded 2011active for 15 yearsRue Haute(VIS) 25, 4600 Visé, BelgiumKBO/BCE: BE 0834.875.832
Summary

PHARMACIE MULLER has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €273,549 and a net result of €47,380. Equity has been growing by about 3.7% per year since 2018. Its solvency ranks better than 76% of 12,775 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-03-2011 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730
Joint committee
313 Paritair Comité voor de apotheken en tarificatiediensten · annual accounts 2025
Establishment unit
2.197.417.610 4600 Visé, since 01-04-2011
Financial year end
31 December
Peppol
Reachable since 18-09-2025

Board and ownership

Board

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€158,883
▲ 16.1%
Turnover
≈ €740,000
estimated
Profit
€47,380
▲ 36.3%
Equity
€273,549
▲ 1.5%
Total assets
€430,209
▲ 7.1%
Employees on 31-12-2025
1
=
Filed on 30-06-2026, 31 days before the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 2.55, cash €227,382Equity €273,549 (63.6% of total assets)Founded in 2011Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 71% of micro companies in retail trade (NACE 47)
Financial strength · tick: 2024
Strong
Solvency 89-3
equity 63.6% of total assets
Liquidity 87-4
short-term debt 30.5% · cash 52.9%
Profitability 83+3
return on assets 11.0%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,272 companies, NACE 47, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025lowest value 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: 0.1%▲ +0.1 percentage points vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €25,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 2.55 (2.98 in 2024), above the usual 1.5. Short-term debt is 30.5% and cash 52.9% of total assets. 36.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 76% of them on solvency, 89% on liquidity, 76% on profitability and 44% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Liquidity: current ratio 2.55, cash €227,382
NBB · annual accounts
lowers risk · Equity €273,549 (63.6% of total assets)
NBB · annual accounts
lowers risk · Founded in 2011
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
raises risk · Sector: Retail trade (NACE 47)
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
34 days early
2023
19 days early
2022
95 days early
2021
13 days early
2020
31 days early
2019
48 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 39 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €47,380 8 years View

Recent changes

  1. · Gazette deed Change of role: RENARD Marie, from manager to director
  2. · Gazette deed Incorporation
All 14 events

Comparable companies

These companies have the same main activity as PHARMACIE MULLER: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €382,000 and €518,000, founded between 2009 and 2011.

CompanyTotal assetsGross margin
PHARMACIE MULLER Visé€430,209€158,883
BENATPHARMA Jette€420,772€159,139
PHARMACIE TOMBEUR Liège€485,800€180,622
KOLTFARMA Charleroi€381,713€179,770
APOTHEEK TAMPERE Oostende€457,212€173,561
Apotheek P. Maenhaut Boutersem€518,236€157,717
Apotheek Werchter Rotselaar€402,771€129,592
Full comparison

Key facts about PHARMACIE MULLER

What is the company number of PHARMACIE MULLER?
The company number of PHARMACIE MULLER is 0834.875.832. The VAT number is the same number with BE in front: BE 0834.875.832.
Where is PHARMACIE MULLER based?
The registered office is at Rue Haute(VIS) 25, 4600 Visé.Company details
What does PHARMACIE MULLER do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMACIE MULLER?
The legal form of PHARMACIE MULLER is Private limited company (BV).
When was PHARMACIE MULLER founded?
PHARMACIE MULLER was founded on 28-03-2011.
Is PHARMACIE MULLER still active?
Yes, PHARMACIE MULLER is an active enterprise in the KBO register.
How many employees does PHARMACIE MULLER have?
PHARMACIE MULLER had an average of 0.7 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMACIE MULLER fall under?
In its 2025 annual accounts, PHARMACIE MULLER states joint committee 313 (Paritair Comité voor de apotheken en tarificatiediensten).
What is the turnover of PHARMACIE MULLER?
The turnover in financial year 2025 is ≈ €740,000. This figure is estimated from the gross margin of €158,883 and 51 comparable companies (NACE 477). It probably lies between €500,000 and €1.4m.
Is PHARMACIE MULLER profitable?
In financial year 2025, PHARMACIE MULLER made a profit of €47,380.
Where can I find the annual accounts of PHARMACIE MULLER?
PHARMACIE MULLER filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACIE MULLER due?
PHARMACIE MULLER must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.